Shotsy
Shotsy GLP-1 Tracker is estimated to make $300k per month from 40k downloads / mo, tracked daily on Peekly.
How Peekly estimates these figuresShotsy is the all-in-one GLP-1 medication tracker for weight loss injections and pills. Track doses of Ozempic®, Wegovy®, Wegovy™ Pill, Mounjaro®, Zepbound®, Rybelsus®, Saxenda®, Victoza®, and Trulicity® — all in one app
Sign in to see this app's ad creatives
Rating & reviews
30k reviews
12 Jun → 1 Jul · best #44
Ads launched per month
Media mix
Sign in to access this metricAds launched per month
Estimated spend:
Sign in to see the ad creatives and library
Shotsy is the all-in-one GLP-1 medication tracker for weight loss injections and pills. Track doses of Ozempic®, Wegovy®, Wegovy™ Pill, Mounjaro®, Zepbound®, Rybelsus®, Saxenda®, Victoza®, and Trulicity® — all in one app. Whether you take semaglutide, tirzepatide, liraglutide, dulaglutide, or retatrutide, Shotsy helps you stay on schedule and reach your goals.
DOSE TRACKING
Log injections or daily pills with a single tap. Track your full medication history, side effects, weight, calories, protein, and water intake. Supports multiple simultaneous medications with separate schedules for each.
SMART SCHEDULING & REMINDERS
Set precise schedules for weekly injections or daily oral doses. Get countdowns, reminders, and next-dose notifications so you never miss a dose.
ESTIMATED MEDICATION LEVELS
See how your medication levels change over time with charts based on peer-reviewed clinical data. Available for semaglutide (Ozempic, Wegovy, Wegovy Pill, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda, Victoza), and dulaglutide (Trulicity).
DETAILED ANALYTICS
Gain insights into your progress with interactive charts and visualizations. Track weight trends, side effects, nutrition, and more.
APPLE HEALTH INTEGRATION
Automatically import weight, calories, protein, and water intake from Apple Health for a complete picture of your health journey.
PRIVACY FIRST
Your personal data is securely stored on your device and synced across your devices using Apple's private iCloud technology. We never sell your data.
Shotsy supports GLP-1 receptor agonists used for weight management and type 2 diabetes, including both weekly injections and daily oral formulations.
Health Disclaimer
Shotsy is designed for tracking and educational purposes only. It is not intended to provide any medical guidance or advice. Always consult with your healthcare provider for any medical decisions or health concerns.
Privacy Policy: https://shotsyapp.com/privacy/
Terms of Use: https://shotsyapp.com/terms/
Rating & reviews
30k reviews
Monetization
Free
No in-app purchases detected
Similar apps
Health & Fitness
Health & Fitness
Health & Fitness
Health & Fitness
Health & Fitness
Health & Fitness
Health & Fitness
Health & Fitness
What's new
Changes in this update: * Add partner-code redemption from links, including links opened before installing Shotsy * Fix imports from older backups so metric history and dosage strengths restore correctly * Improve startup reliability when saved data is temporarily unavailable * Improve weight chart accuracy and prevent outdated results when chart settings change quickly * Improve dose reminder reliability when schedules change * Improve medication selectors for long medication type names
How much does Shotsy GLP-1 Tracker make?
Shotsy GLP-1 Tracker is estimated to make $300k per month, according to Peekly's daily tracking.
How many downloads does Shotsy GLP-1 Tracker have?
Shotsy GLP-1 Tracker has an estimated 40k downloads / mo on the App Store.
Is Shotsy GLP-1 Tracker free?
Shotsy GLP-1 Tracker is free to download.
What is Shotsy GLP-1 Tracker's rating?
Shotsy GLP-1 Tracker has a rating of 4.8 out of 5, based on 30k reviews.
Publisher
Shotsy
Category
Health & Fitness
Compatibility
18.0
Size
119 MB
Rating
12+
Price
Free
Released
—
Last update
Aug 8, 2026
Languages
17 available
Sign in to see captured paywall screens
Market context
Compare its revenue, downloads and momentum, then study the ads and paywalls competitors use to acquire and monetize users.